Engineers Gate Manager’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
JT
FFM
DM
TCM
Engineers Gate Manager's COGT Position: Q2 2026 in Review
Engineers Gate Manager reduced its Cogent Biosciences (COGT) stake by 71% in Q2 2026, selling an estimated $1.04M and leaving 12,267 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #1551.
Engineers Gate Manager first reported a position in COGT in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.62M in Q1 2026. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- Engineers Gate Manager held 12,267 shares of Cogent Biosciences worth $475K as of Q2 2026.
- Engineers Gate Manager sold 29,723 Cogent Biosciences shares in Q2 2026, an estimated $1.04M.
- Cogent Biosciences made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1551 holding.
- Engineers Gate Manager first reported a position in Cogent Biosciences in Q1 2021 and has held it in 12 quarters since.
- Engineers Gate Manager's Cogent Biosciences position peaked at $1.62M in Q1 2026.
- 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.